[HTML][HTML] A ferroptosis-related signature robustly predicts clinical outcomes and associates with immune microenvironment for thyroid cancer

M Ge, J Niu, P Hu, A Tong, Y Dai, F Xu, F Li - Frontiers in Medicine, 2021 - frontiersin.org
Objective: This study aimed to construct a prognostic ferroptosis-related signature for thyroid
cancer and probe into the association with tumor immune microenvironment. Methods …

[HTML][HTML] How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?

N Mukhtar, K Alhamoudi, M Alswailem… - Frontiers in …, 2023 - frontiersin.org
Context The American Thyroid Association risk stratification (ATA) and the American Joint
Committee on Cancer Tumor Node Metastases (TNM) predict recurrence and mortality of …

[HTML][HTML] SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway

J Ma, X Huang, J Xu, Z Li, J Lai, Y Shen, J Zhao… - Molecular …, 2023 - Springer
Background As the tissue with the highest selenium content in the body, the occurrence and
development of thyroid cancer are closely related to selenium and selenoproteins. Selenium …

Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells

Q Lin, Q Qi, S Hou, Z Chen, N Jiang, L Zhang, C Lin - Tissue and Cell, 2021 - Elsevier
Kinesin family member 2C (KIF2C) has been identified as a potential oncogene in various
types of human cancers; however, the role of KIF2C in thyroid cancer has not yet been …

[HTML][HTML] YAP1 and P53 expression in papillary thyroid carcinoma

DN Abdelhafez, MM Ayoub, SA Mahmoud… - Iranian journal of …, 2023 - ncbi.nlm.nih.gov
Methods: The current study used paraffin blocks of 60 cases of papillary thyroid carcinoma,
which were immunohistochemically assessed for YAP1 and p53 expression. The study …

LncRNA ATP1A1-AS1 inhibits cell proliferation and promotes cell apoptosis in thyroid carcinoma by regulating the miR-620/IRF2BP2 axis

J Jia, Y Liu, X Yang, Z Wu, X Xu, F Kang… - The American Journal of …, 2023 - Elsevier
Background Thyroid carcinoma (THCA) is a common malignancy of the endocrine system.
Further understanding of the molecular mechanism underlying THCA is crucial to develop …

OPEN ACCESS EDITED BY

A Nicolò, M Lemire, SP Dufour, P Wicker… - Breathing in Sport …, 2023 - books.google.com
OPEN ACCESS EDITED BY Page 114 TYPE Original Research frontiers Frontiers in Physiology
PUBLISHED 21 September 2022 DOI 10.3389/fphys. 2022.949351 Check for updates OPEN …

Expression von PD-L1 und FGFR1-4 beim anaplastischen und gering differenzierten Schilddrüsenkarzinom-Evaluation als präklinische diagnostische Marker

PS Adam - 2024 - opus.bibliothek.uni-wuerzburg.de
Hintergrund: Die therapeutischen Optionen für das gering differenzierte (PDTC) und
anaplastische (ATC) Schilddrüsenkarzinom sind limitiert, weshalb diese Erkrankungen …

[PDF][PDF] Aus der Klinik und Poliklinik I

PS Adam - d-nb.info
Die Schilddrüse ist ein H-oder schmetterlingsförmiges Organ, das aus zwei Lappen, die
durch den Isthmus verbunden sind, besteht, und in Höhe der Halswirbel C6/C7 dem unteren …

Avaliação imunoistoquímica da yap-1 em carcinomas papilíferos de tireoide

HES Costa - 2023 - repositorio.ufrn.br
The Papillary thyroid carcinoma (PTC) is a malignant lesion belonging to the family of well-
differentiated thyroid carcinomas and is the most common endocrine neoplasm. The …